AMRN Q3 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M-26.5% YoY

Gross Profit

$30M45.1% margin

Operating Income

-$21M-32.5% margin

Net Income

-$19M-29.2% margin

EPS (Diluted)

$-0.95

QoQ Revenue Growth

-17.6%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$839M

Total Liabilities

$286M

Stockholders' Equity

$553M

Cash & Equivalents

$271M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$90M	-26.5%
Gross Profit	$30M	$63M	-52.6%
Operating Income	-$21M	-$5M	-317.0%
Net Income	-$19M	-$5M	-275.7%

Revenue Segments

Product

$65M98%

Licensing And Royalty

$1M2%